Korro Bio Inc [NASDAQ: KRRO] traded at a low on 2025-11-13, posting a -79.31 loss after which it closed the day’ session at $6.5.
The results of the trading session contributed to over 8282786 shares changing hands. Over the past one week, the price volatility of Korro Bio Inc stands at 13.07% while the volatility over the past one month is 12.15%.
The market cap for KRRO stock reached $61.04 million, with 9.40 million shares outstanding and 5.46 million shares in the current float. Compared to the average trading volume of 279.04K shares, KRRO reached a trading volume of 8282786 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Korro Bio Inc [KRRO]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for KRRO shares is $29.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on KRRO stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Korro Bio Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on November 13, 2025. The new note on the price target was released on November 13, 2025, representing the official price target for Korro Bio Inc stock.
The Price to Book ratio for the last quarter was 0.62, with the Price to Cash per share for the same quarter was set at 9.95.
How has KRRO stock performed recently?
Korro Bio Inc [KRRO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -80.04. With this latest performance, KRRO shares dropped by -87.34% in over the last four-week period, additionally sinking by -55.11% over the last 6 months – not to mention a drop of -82.93% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for KRRO stock in for the last two-week period is set at 20.27, with the RSI for the last a single of trading hit 6.37, and the three-weeks RSI is set at 5.27 for Korro Bio Inc [KRRO]. The present Moving Average for the last 50 days of trading for this stock 38.25, while it was recorded at 27.44 for the last single week of trading, and 23.41 for the last 200 days.
Korro Bio Inc [KRRO]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Korro Bio Inc [KRRO] shares currently have an operating margin of -1282.04% and a Gross Margin at 33.82%. Korro Bio Inc’s Net Margin is presently recorded at -1199.53%.
Korro Bio Inc (KRRO) Capital Structure & Debt Analysis
According to recent financial data for Korro Bio Inc. ( KRRO), the Return on Equity (ROE) stands at -63.46%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -43.65%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Korro Bio Inc’s Return on Invested Capital (ROIC) is -62.91%, showcasing its effectiveness in deploying capital for earnings.
Korro Bio Inc (KRRO) Efficiency & Liquidity Metrics
Based on Korro Bio Inc’s (KRRO) latest financial statements, the Debt-to-Equity Ratio is 0.45%, indicating its reliance on debt financing relative to shareholder equity.
Korro Bio Inc (KRRO) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Korro Bio Inc. (KRRO) effectively leverages its workforce, generating an average of -$850192.31 per employee. The company’s liquidity position is robust, with a Current Ratio of 6.71% and a Quick Ratio of 6.71%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Korro Bio Inc [KRRO]
With the latest financial reports released by the company, Korro Bio Inc posted -2.26/share EPS, while the average EPS was predicted by analysts to be reported at -2.51/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.25. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for KRRO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Korro Bio Inc go to 4.40%.
Insider trade positions for Korro Bio Inc [KRRO]
There are presently around $99.52%, or 106.07%% of KRRO stock, in the hands of institutional investors. The top three institutional holders of KRRO stocks are: ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with ownership of 1.14 million shares, which is approximately 12.6539%. NEA MANAGEMENT COMPANY, LLC, holding 1.09 million shares of the stock with an approximate value of $$36.95 million in KRRO stocks shares; and NEA MANAGEMENT COMPANY, LLC, currently with $$26.1 million in KRRO stock with ownership which is approximately 8.5755%.
